Sep 02, 2026
309:500
For every 500 shares held, investors received 309. The price per share adjusted from $16.65 to $26.94.
The split itself did not change the total investment value.
Intech Biopharm Ltd (TPEX:6461) operates in the Pharmaceuticals: major industry.
Intech Biopharm Ltd company overviewIntech Biopharm Ltd's most recent stock split was on September 2, 2026. It was a 309-for-500 reverse split, so shareholders received 309 shares for every 500 they held.
Intech Biopharm Ltd (TPEX:6461) has split its stock 6 times: a 707-for-701 split on January 20, 2016, a 478-for-471 split on October 28, 2019, a 166-for-165 split on November 9, 2021, a 313-for-305 split on September 26, 2023, a 849-for-835 split on May 22, 2025, and a 309-for-500 reverse split on September 2, 2026.
Intech Biopharm Ltd has split its stock 6 times. This history records 6 splits between January 20, 2016 and September 2, 2026.
A reverse stock split combines several shares into one and raises the price per share by the same factor, so the total value of a holding does not change. In Intech Biopharm Ltd's 309-for-500 reverse split on September 2, 2026, every 500 shares became 309 shares. Companies often use reverse splits to lift a low share price, for example to keep meeting an exchange's minimum price requirement.
Intech Biopharm Ltd has not announced a new split in our records. Its most recent split was on September 2, 2026, less than a year ago. Companies announce splits in advance, and any new TPEX:6461 split will appear on this page.
Already premium?